Oncology & Immunology

Expert reports about Oncology & Immunology


THE SAFETY OF TOFACITINIB (XELJANZ) DURING PREGNANCY OR BREASTFEEDING

 

THIS MEDICATION CAN CAUSE HARM TO YOUR BABY espicially when combined with methotrexate during pregnancy.


TO READ THE FULL REPORT

Join Pregistry to access the information you need at no cost to you

Join Pregistry